Anti-tumor effect of ardicrenin against MG63 osteosarcoma cells
Bioorganic & Medicinal Chemistry Letters · 2026
DOI: 10.1016/j.bmcl.2026.130558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026. Verfasst von Qingsu Cheng. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering and Applied Science, University of Wisconsin-Milwaukee, Milwaukee, WI 53201, United Stat…. Hauptthemen laut MEDLINE: Osteosarcoma, Antineoplastic Agents, Phytogenic, Antineoplastic Agents. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Cancer remains one of the leading causes of mortality worldwide. As a result, bioactive compounds derived from herbal medicines have gained increasing attention in cancer research. Ardicrenin, extracted from Ardisia crenata, has been evaluated for its ability to suppress the growth of MG-63 cells. Remarkably, its inhibitory effect on MG-63 cell proliferation is comparable to that of Taxol. Unlike Taxol, which induces apoptosis by stabilizing microtubules, ardicrenin regulates cell proliferation and death through the integrin signaling pathway. These findings highlight ardicrenin as a promising candidate for anti-tumor drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Engineering and Applied Science, University of Wisconsin-Milwaukee, Milwaukee, WI 53201, United States. Electronic address: chengq@uwm.edu.
Zitieren
APA
Cheng, Q. (2026). Anti-tumor effect of ardicrenin against MG63 osteosarcoma cells. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2026.130558
Vancouver
Cheng Q. Anti-tumor effect of ardicrenin against MG63 osteosarcoma cells. Bioorganic & Medicinal Chemistry Letters. 2026. doi:10.1016/j.bmcl.2026.130558
BibTeX
@article{Cheng2026,
author = {Cheng, Qingsu},
title = {Anti-tumor effect of ardicrenin against MG63 osteosarcoma cells},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2026},
doi = {10.1016/j.bmcl.2026.130558}
}
EUVIMED